KEGG   DRUG: Fulranumab
Entry
D09907                      Drug                                   
Name
Fulranumab (USAN/INN)
Formula
C6446H9930N1718O2018S50
Exact mass
145293.325
Mol weight
145383.3662
Sequence
(Heavy chain)
EVQLVESGGG LVQPGGSLRL SCAASGFTLR SYSMNWVRQA PGKGLEWVSY ISRSSHTIFY
ADSVKGRFTI SRDNAKNSLY LQMDSLRDED TAMYYCARVY SSGWHVSDYF DYWGQGILVT
VSSASTKGPS VFPLAPCSRS TSESTAALGC LVKDYFPEPV TVSWNSGALT SGVHTFPAVL
QSSGLYSLSS VVTVPSSNFG TQTYTCNVDH KPSNTKVDKT VERKCCVECP PCPAPPVAGP
SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVQFNWY VDGVEVHNAK TKPREEQFNS
TFRVVSVLTV VHQDWLNGKE YKCKVSNKGL PAPIEKTISK TKGQPREPQV YTLPPSREEM
TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPML DSDGSFFLYS KLTVDKSRWQ
QGNVFSCSVM HEALHNHYTQ KSLSLSPGK
(Light chain)
AIQLTQSPSS LSASVGDRVT ITCRASQGIS SALAWYQQKP GKAPKLLIYD ASSLESGVPS
RFSGSGSGTD FTLTISSLQP EDFATYYCQQ FNSYPLTFGG GTKVEIKRTV AAPSVFIFPP
SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
(Disulfide bridge: H22-H96, H150-H206, H263-H323, H369-H427, H225-H'225, H226-H'226, H229-H'229, H232-H'232, L23-L88, L134-L194, H137-L214)
  Type
Peptide
Efficacy
Analgesic, Anti-nerve growth factor antibody
  Type
Monoclonal antibody
Comment
Treatment of pain
Target
NGF [HSA:4803] [KO:K02582]
  Pathway
hsa04010  MAPK signaling pathway
hsa04210  Apoptosis
hsa04722  Neurotrophin signaling pathway
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokines
   Growth factors (RTK-binding)
    NGF
     D09907  Fulranumab (USAN/INN)
Other DBs
CAS: 902141-80-4
PubChem: 124490614
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system